Skip to content Skip to main menu Skip to utility menu

Drug Safety Notice – Zanamivir (Dectova®)

January 10, 2025

Problem

  • There is a shortage of Zanamivir (Dectova®) 200mg/20ml solution for infusion.
  • This is expected to continue until at least February.

Action

  • Adhere to the Trust Policy for the prevention and control of influenza which includes
    national treatment algorithms from UKHSA Guidance on use of antiviral agents for the
    treatment and prophylaxis of seasonal influenza.
  • Other treatments for influenza remain available. IV Zanamivir is seldom first line.
  • Discuss any proposed use of IV Zanamivir with Microbiology before initiating.
  • Where IV Zanamivir is required contact pharmacy who can advise on availability.

For alternatives, supporting information and key resources – click here